These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 8207400)

  • 1. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
    Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of mice vaccinated with rabies virus internal structural proteins to lethal infection.
    Takita-Sonoda Y; Fujii H; Mifune K; Ito Y; Hiraga M; Nishizono A; Mannen K; Minamoto N
    Arch Virol; 1993; 132(1-2):51-65. PubMed ID: 8352659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
    Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
    Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and relative attenuation of different vaccinia-rabies virus recombinants.
    Zhu JH; Wang J; Cai B; Zhao W; Zhu Y; Chao R; Chen L; Xue H; Ying BL; Li CP; Hu QL; Sha J; Esposito JJ
    Arch Virol; 1996; 141(6):1055-65. PubMed ID: 8712923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein.
    Sumner JW; Fekadu M; Shaddock JH; Esposito JJ; Bellini WJ
    Virology; 1991 Aug; 183(2):703-10. PubMed ID: 1840709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
    Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
    Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.
    Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD
    Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
    Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
    Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W; Zhang Y; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.
    Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF
    Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus].
    Shmarov MM; Tutykhina IL; Logunov DIu; Verkhovskai LV; Nedosekov VV; Tsybanov SZh; Novikov BV; Narodnitskiĭ BS; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):69-71. PubMed ID: 16941876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
    Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
    Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein.
    Fekadu M; Shaddock JH; Sumner JW; Sanderlin DW; Knight JC; Esposito JJ; Baer GM
    J Wildl Dis; 1991 Oct; 27(4):681-4. PubMed ID: 1758034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production of monoclonal antibodies against a wild strain of rabies virus].
    Akacem O; Benmansour A; Coulon P; Brahimi M; Benhassine M
    Arch Inst Pasteur Alger; 1992; 58():283-90. PubMed ID: 1309144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
    Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
    Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant replication-defective adenovirus based rabies vaccine].
    Li WH; Zhang Y; Wang SH; Liu L; Yang F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):650-4. PubMed ID: 14714304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein.
    Fu ZF; Rupprecht CE; Dietzschold B; Saikumar P; Niu HS; Babka I; Wunner WH; Koprowski H
    Vaccine; 1993; 11(9):925-8. PubMed ID: 8212838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
    Turki I; Hammami A; Kharmachi H; Mousli M
    Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice.
    Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X
    Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.